Introduction
Prader ± Willi syndrome (PWS; MIM 176270) and Angelman syndrome (AS; MIM 105830) are two distinct disorders which are caused by a loss of function of imprinted genes on proximal 15q. At the molecular level, the parental alleles of the PWS/AS region can be distinguished by DNA methylation, and therefore methylation analysis can be used as a diagnostic tool for both syndromes. Although many differentially methylated sites in 15q11-q13 have been identified, typically D15S63 (PW71) and/or SNURF-SNRPN exon 1 are investigated. 1, 2 Changes in the parent-specific methylation pattern at these loci are most often due to a large deletion or uniparental disomy (UPD). However, a small group (2 ± 4%) of patients have apparently normal chromosomes of biparental origin, but uniparental DNA methylation 2 ± 8 and gene expression. 9 These patients have an imprinting defect. In some (10 ± 15%) of these patients the incorrect epigenotype of one of the chromosomes is caused by a deletion in the imprinting centre (IC).
5,9 ± 13
Although more extended methylation studies have been performed in special cases, 5, 10, 12 no systematic investigation of the methylation pattern at different loci in patients with an imprinting defect has been reported so far. Therefore, it was not clear (i) whether the imprinting defect affected only some loci or the whole imprinted domain, and (ii) whetherdirection or uniformly methylated and unmethylated, respectively. To address these questions, we performed a comprehensive methylation analysis in 12 AS and PWS patients with an imprinting defect by investigating loci which are normally methylated on the maternal allele and loci which are normally methylated on the paternal allele. Furthermore, we studied four patients suspected of having PWS or AS who by routine diagnostic testing had been found to have normal SNURF-SNRPN, but abnormal D15S63 methylation. In the course of this work we have developed a methylation-specific PCR (MSP) test for D15S63. This test may be useful to confirm results obtained by methylation analysis of the SNURF-SNRPN gene, which is the most suitable locus for testing patients.
Patients
Patients with an imprinting defect Twelve patients with an imprinting defect were seen by experienced clinicians and diagnosed as having typical AS or PWS. Patients AS1 and AS6 were described by Bu Èrger et al.
6
(AS-La and AS-D). Patients AS2, 3 and 4 were described by Buiting et al. 7 where they are referred to as ASID-04, ASID-06
and ASID-10. One of the AS patients with an imprinting defect (AS5) was described in Ohta et al.
(case ASF).
The first five patients with PWS and a sporadic imprinting defect (PWS1 ± 5) were reported in Buiting et al, 7 named PWSID-02, PWSID-05, PWSID-06, PWSID-07 and PWSID-12.
The PWS patient with an IC-deletion (PWS6) was described in Ohta et al.
(PWS-P).
Patients with an abnormal methylation pattern By routine diagnostic testing for AS and PWS we identified four patients who had a normal SNURF-SNRPN, but abnormal D15S63 methylation.
Patient LE The proposita was born at term as the first child of a non-consanguineous German couple. A younger brother is developing normally. Birth weight of the patient was 2510 g (72.8 SD), length 47 cm (73.2 SD) and occipitofrontal circumference (OFC) was 31.5 cm (72.6 SD). During the neonatal period she had feeding problems but no severe muscular hypotonia. The developmental milestones were delayed. She began to walk at the age of 2 years and to speak at the age of 4 years. Since the age of 2 years, she is obese and does not feel satiety. She was referred to a clinical genetics department (GG-K) at the age of 5 years and 10 months with the tentative diagnosis of Prader ± Willi syndrome. Her height was 108.4 cm (3 ± 10th percentile). She was severely obese with a weight of 24.5 kg (497th percentile). OFC of 50.5 cm corresponded to the 25th percentile. She was mentally retarded and showed general obesity but no muscular hypotonia. Facial features were normal. Apart from clinodactyly of digitus V she had no characteristic dysmorphic signs. By microsatellite analyses, a common large deletion and a UPD could be excluded. Cytogenetic analysis showed a normal karyotype (46,XX).
Patient FB The patient was born as the 4th child of a healthy nonconsanguineous couple. The three sibs are normal and healthy. The propositus was born at term with a birth weight of 4300 g (+1.7 SD), and a length of 55 cm (+0.6 SD). During pregnancy the mother noticed reduced foetal movements. The boy had neither neonatal feeding problems nor muscular hypotonia. Sleep problems were reported during the first 2 years of life. He began to walk at 19 months and to speak at about 3 years and 6 months. The mentally retarded boy was examined (GG-K) at the age of 8 years and 9 months. His height was 149 cm (497th percentile) and he was markedly obese with a weight of 56 kg (497th percentile). His bone age was accelerated (12 years) and he had developed signs of a precocious puberty. No dysmorphic signs were present. He tended to be aggressive. Microsatellite analysis showed a normal biparental inheritance.
Patient MK The patient was born in August 1984 after a normal pregnancy as the first child to healthy unrelated parents with an unremarkable family history. He was delivered by caesarean section as a floppy baby. Breast feeding was impossible, and he regurgitated for the first 6 months. He was first seen by a paediatrician after 8 days. He had delayed milestones and began to walk just 3 weeks before his second birthday. Furthermore speech was missing and he had an L convergent squint. One of his testes was undescended. He has a high palate as well as blue eyes and brown hair and is not hypopigmented. His 5th fingers show bilateral clinodactyly. When seen in 1993 he had sleep problems, but had no signs of epilepsy. He had an ataxic gait. Furthermore, he had a large mouth and a big chin. He was a happy child that laughed a lot and inappropriately. He was able to understand and used a basic sign language with about 15 words. He was toilet trained. His weight was 35 kg (90th percentile), his height 130.4 cm (25 ± 50th percentile), and his head circumference was 55.5 cm (nearly 98th percentile). When he was last seen in 1996 his puberty developed normally and he still did not present any sign of epilepsy. His head circumference and height were still above the 90th percentile. Exept for the large head circumference the patient showed typical features for AS. Microsatellite analysis showed normal biparental inheritance and also excluded a typical deletion. This was confirmed by fluorescence-in situ-hybridisation.
Patient MC
The proposita was born in 1950 to unrelated Caucasian parents. Her mother was 28 years old at the time of delivery, which was unremarkable. She had had two miscarriages before. From the age of 6 months, the patient had episodes of generalised seizures. Developmental milestones and speech
Methylation defects in PWS and AS M Runte et al 520 were delayed. She began to walk at 24 months and was severely mentally retarded. She showed signs of primary thrombocythemia (platelet count between 700 and 800 000/ mm 3 ) and polyglobulism with thromboembolic events (lower limbs thrombosis, pulmonary embolism, myocardial infarction). She still has recurrent seizures, which are very difficult to control with antiepileptic drugs. On clinical examination at age 41, her height was 153 cm (72 SD) and OFC was 54 cm. There is midface hypoplasia, downslanting palpebral fissures and telecanthus, low set ears, flat occiput and bilateral epicanthus. On slit lamp examination of the eye, she showed a bilateral cataract and a normal fundus. Cytogenetic analysis of peripheral lymphocytes presented a normal 46,XX karyotype.
Methods
DNA methylation analysis by Southern blotting DNA from peripheral blood (2 mg each) was digested with the appropriate restriction enzymes. The fragments were resolved on 0.7 to 1.0% agarose gels and transferred to Biodyne A nylon membranes (PALL, Portsmouth, UK). All Southern blots were performed in duplicates. Probes were labelled by random oligonucleotide priming and [a- For methylation analysis in 15q11-q13 the following probes were used: a cDNA clone 14 or a PCR derived probe generated with primers RN700 and RN709 (kindly provided by RD Nicholls) for the NDN locus, probe B800 and D800 for u1D and u1B, respectively, 15 Exclusion of structural rearrangements or deletions of the IC region was performed using PCR generated probes Snpwsct2a (309 bp), Snpwsct5a (131 bp), Snpwsct9a (531 bp), and Snpwsct12a (1.2 kb). Each probe was hybridised onto EcoRI, BamHI, HindIII, XbaI, and ScaI digested DNA of the patients. These probes were generated using following primers: 
Results and discussion
Methylation analysis in patients with an imprinting defect We studied six PWS and six AS patients. One PWS and two AS patients had an inherited deletion in the imprinting centre. The other nine patients had a sporadic imprinting defect. and YL48E (K Buiting, unpublished). These loci include two sites which are normally methylated on the maternal chromosome (NDN, u1B) and three sites which are preferentially methylated on the paternal chromosome (u1D, SNURF-SNRPN intron 7, YL48E). The results are shown in Figure 1 and summarised in Figure 2 . We found that in most cells all loci were incorrectly methylated: In the AS patients, the maternal chromosome was unmethylated at sites that should be methylated, and methylated at sites that should be unmethylated. The reciprocal findings were made on the paternal chromosome of PWS patients. These results indicate that the defect affects the whole imprinted domain and that the affected chromosomes are imprinted in the opposite direction rather than methylated or unmethylated. There was no difference between patients with an IC deletion or a sporadic imprinting defect.
Detection of unusual methylation patterns
In the course of routine diagnostic testing we identified four patients who had a normal methylation pattern at SNURF-SNRPN exon 1, but an abnormal pattern at D15S63. Two of the patients (LE und FB) had a weak maternal band and a strong paternal band at the CfoI site within exon u1A, ie an AS-like pattern, although they were suspected of having PWS (Figure 3) . The other two patients (MK and MC) had a strong maternal band and a faint paternal band at the CfoI-site, ie a PWS-like pattern, although they were suspected of having AS
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Southern blot analysis with a battery of probes covering about 35 kb of genomic DNA of the IC (data not shown).
To find out whether the aberrant methylation pattern in the four patients was restricted to D15S63, we investigated Figure 1 Methylation analysis of patients with an imprinting defect. Patients AS4, AS6 and PWS 6 have an IC deletion, whereas the other patients have a sporadic imprinting defect. PWS del and AS del represent patients with a de novo common large deletion of 15q11-q13. The fragment sizes of the paternal (pat) and maternal (mat) alleles are as follows: NDN 2.7 kb (mat), 1.74 kb (pat), 1.7 kb (mat/pat), 0.9 kb (pat); u1D: 13.0 kb (pat), 9.0 kb (mat); u1B: 9.2 kb (mat), 7.4 kb (pat), 1.6 kb (pat; not shown); for SNRPN intron 7: 7.5 kb (SNRPNP1; SNURF-SNRPN pseudogene on chromosome 6), 5.8 kb (mat/pat), 5.0 kb (mat), 4.5 kb (exon 3); YL48E: 3.0 kb (mat/pat), 2.6 kb (mat). All the AS patients have a faint or absent maternal band whereas all the PWS patients have a faint or absent paternal band.
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M Runte et al 522 the loci mentioned above plus 71.19.12 (B Dittrich, unpublished), the long terminal repeat (LTR) at locus PW71 1 and YR9AB 18 ( Figure 3 ), which are methylated on the maternal chromosome. Patients LE and FB had a normal biparental methylation pattern at each locus except for the CfoI site mentioned above. Interestingly, the HpaII site within the D15S63 locus, which was mapped 1.3 kb distal to the CfoI site, was normal. In the parents of LE and FB, the CfoI site was normally methylated (data not shown).
In patient MK we found that four sites were affected: one HpaII site detected by probe Y48.5, one HpaII site detected by probe YR9AB, and the HpaII and CfoI site detected by probe PW71 (D15S63). All four sites were hypermethylated on the paternal chromosome. The aberrantly methylated region spans approximately 50 kb. In the parents, these sites were normally methylated (data not shown).
In patient MC we found that eight sites were affected. While YR9AB was hypomethylated on the maternal allele, Figure 2 Schematic representation of the methylation status in the PWS and AS patients with an imprinting defect (ID) and the patients LE, FB, MK and MC. u1D, u1B and u1A are alternative 5' exons of the IC/SNRPN-transcripts. 24, 25 The boxes show the degree of methylation in grey. Stars indicate an aberrant pattern. In patient MC, the parental identity of the aberrant pattern at loci Y48.5 and YL48E is unclear (indicated by question marks).
the two D15S63 restriction sites, 71.19.12 and u1B were hypermethylated on the paternal allele. u1D was hypomethylated on the paternal allele. We also observed methylation changes at Y48.5 and YL48E, but were unable to resolve which chromosome was affected. This is due to the fact that in normal controls differential methylation at these two loci is not as complete as at other loci. Apart from SNURF-SNRPN, only NDN was normal.
The aberrant methylation affects seven loci centromeric to SNURF-SNRPN spanning 140 kb, and one locus which maps 200 kb telomeric to SNURF-SNRPN (YL48E). Unfortunately, no parental DNA samples were available for testing.
To find out whether aberrant methylation in the four patients might be due to a trans-acting defect affecting other imprinted regions as well, we studied a NotI site at the maternally methylated CpG island (KvDMR1) within intron 10 of the KvLQT1 locus on 11p15, which is often affected in patients with Beckwith ± Wiedemann syndrome. 21, 29 We observed a normal pattern in each patient (data not shown).
Next we asked how frequent methylation changes outside SNURF-SNRPN might be. For this, we investigated 48 patients with normal SNURF-SNRPN methylation who had been suspected of having AS, but who did not have a UBE3A mutation. We developed a methylation-specific PCR (MSP) test for the CfoI site at D15S63. The density of CpG dinucleotides in this region is much lower than in the SNURF-SNRPN exon 1 region. After bisulfite modification there are only two nucleotides, which can be used to distinguish the parental alleles. 30 PCR is initiated with a primer (PW71com) annealing to a site which is identical in both alleles. Methylation specific primers were designed to specifically bind to the paternal strand (PW71pat) and the maternal strand (PW71mat23C), respectively, both with their 3' end annealing to the differentially methylated CfoI site. To distinguish between the parental alleles in a single tube MSP assay, primer PW71mat23C was designed to have a 5' tail of 23 cytosines, resulting in a maternal MSP product of 161 bp and a paternal product of 143 bp in length. The test was validated by investigating normal controls and patients who had been typed by Southern blot analysis (Figure 4a ). The primers can be combined with the previously published SNURF-SNRPN MSP primers 22 in a multiplex assay (Figure 4b ).
All of the 48 patients had a normal pattern (data not shown), suggesting that methylation changes outside of SNURF-SNRPN in this class of patients are rare. What is the significance of our findings? We cannot prove that the unusual methylation changes in the four patients are related to their disease, especially since we found an`AS-like' methylation pattern in two patients suspected of having PWS and a`PWS-like' methylation pattern in two patients suspected of having AS. The first two patients (LE and FB) have only few features of PWS. In these patients, the methylation change is restricted to one site at the D15S63 locus and may reflect a change in the clonal complexity of peripheral blood. LaSalle et al 31 have recently shown that the methylation pattern at this locus is not strictly maintained within individual cell clones and displays clonal heterogeneity. Despite clonal variation in D15S63 methylation, peripheral blood is usually very complex due to the generation of diversity for its immune function. It is possible that this complexity and not the imprint itself is disturbed in the two patients. The same argument may apply to the other two patients, but in these patients other loci in addition to D15S63 are affected. Whereas patient MC has only few features of AS, patient MK is rather typical. It is possible that in these cases imprinting was indeed affected. One may speculate that the imprint was correctly switched at the imprinting centre, but that the spreading was incomplete. 
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